Listen: What the mifepristone case means, GLP-1 skepticism, & Chinese biotech
Who gets to sue the FDA? Is pharma caught in a trade war? And what does “AF” stand for?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Sarah Owermohle joins us to explain the Supreme Court case that could have dramatic effects on access to medication abortion — and the development of new medicines. We also discuss the latest news in the life sciences, including a contrarian take on a new obesity treatment, a congressional effort to ban Chinese biotech companies, and how we managed to make 300 episodes of this podcast.
